ENTERAL SUPPLEMENTATION OF PHOSPHATE DOES NOT PREVENT HYPOPHOSPHATEMIA DURING REFEEDING OF CACHECTIC PATIENTS

被引:17
|
作者
MAIERDOBERSBERGER, T
LOCHS, H
机构
[1] University School of Medicine, Department of Gastroenterology and Hepatology, Währinger Gürtel, Vienna
关键词
D O I
10.1177/0148607194018002182
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Hypophosphatemia due to parenteral nutrition has been described frequently. It was attributed to the lack of phosphorus content in parenteral nutrition solutions. With modem parenteral nutrition regimens containing phosphorus, this problem has been virtually eliminated. Enteral nutrition solutions contain adequate phosphate for patients with normal phosphate stores. Hypophosphatemia has therefore rarely been reported in enteral nutrition. We describe two patients with protein-energy malnutrition who developed severe hypophosphatemia during tube feeding with phosphorus-containing formula diets. Chronic alcoholism and vitamin D deficiency due to malabsorption because of Crohn's disease were additional risk factors in these two patients. Patients with depleted phosphate stores and high metabolic demand have a higher daily requirement for phosphorus than is available in routine isotonic enteral formulas. This case report emphasizes the importance of monitoring serum phosphate concentration daily during the first week of refeeding.
引用
收藏
页码:182 / 184
页数:3
相关论文
共 44 条
  • [31] Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?
    Storm, Christian
    Joerres, Achim
    CRITICAL CARE, 2008, 12 (06):
  • [32] Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?
    Christian Storm
    Achim Jörres
    Critical Care, 12
  • [33] Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection
    Aoyama, Hiroki
    Otsuka, Yuji
    Aoyama, Yuka
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (12) : 735 - 741
  • [34] Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection
    Hiroki Aoyama
    Yuji Otsuka
    Yuka Aoyama
    General Thoracic and Cardiovascular Surgery, 2016, 64 : 735 - 741
  • [35] EVIDENCE FOR DIMINISHED B-12 ABSORPTION AFTER GASTRIC BYPASS - ORAL SUPPLEMENTATION DOES NOT PREVENT LOW PLASMA B-12 LEVELS IN BYPASS PATIENTS
    PROVENZALE, D
    REINHOLD, RB
    GOLNER, B
    IRWIN, V
    DALLAL, GE
    PAPATHANASOPOULOS, N
    SAHYOUN, N
    SAMLOFF, IM
    RUSSELL, RM
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1992, 11 (01) : 29 - 35
  • [36] Maternal Oxygen (O2) Supplementation During Prolonged Uterine Blood Flow (Ut BF) Reduction Does Not Prevent Fetal Growth Restriction In Sheep. 234
    David W. Boyle
    Scott C. Denne
    Edward A. Liechty
    Pediatric Research, 1997, 41 (Suppl 4) : 41 - 41
  • [37] Why does oxygen supplementation during exercise training in COPD patients with exercise-induced desaturation not consistently improve exercise capacity?
    Langer, Daniel
    Gosselink, Rik
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (05)
  • [38] Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life
    Fouque, Denis
    McKenzie, Jane
    de Mutsert, Renee
    Azar, Raymond
    Teta, Daniel
    Plauth, Mathias
    Cano, Noel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (09) : 2902 - 2910
  • [39] Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial
    Kyrou, D.
    Fatemi, H. M.
    Zepiridis, L.
    Riva, A.
    Papanikolaou, E. G.
    Tarlatzis, B. C.
    Devroey, P.
    HUMAN REPRODUCTION, 2011, 26 (05) : 1020 - 1024
  • [40] LOW-DOSE ASPIRIN DOES NOT PREVENT THROMBOVASCULAR ACCIDENTS IN LOW-RISK HEMODIALYSIS-PATIENTS DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    KOOISTRA, MP
    VANES, A
    MARX, JJM
    HERTSIG, MLA
    STRUYVENBERG, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) : 1115 - 1120